Physician profile
Sarah M Crafton
NPI 1144517699
$46,365.35
in general payments reported to CMS, 2019-2025
17 companies · $24K in 2025
The $24K reported for 2025 was more than what 95% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,520 · 2021: $108 · 2022: $639 · 2023: $595 · 2024: $6,057 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $5,095 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,625 · Food and Beverage: $2,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,086.08 |
| Travel and Lodging | $5,095.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,625.00 |
| Food and Beverage | $2,193.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11,024.86 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $7,895.99 | 2019-2025 | Lynparza |
| Glaxosmithkline, LLC. | $6,001.90 | 2020-2025 | Jemperli |
| Corcept Therapeutics | $5,499.11 | 2025 | |
| Medtronic, INC. | $4,622.16 | 2025 | Auto Suture |
| Karyopharm Therapeutics INC. | $4,450.58 | 2024 | Xpovio |
| Tesaro, INC. | $4,033.47 | 2019 | |
| Merck Sharp & Dohme LLC | $1,763.40 | 2019-2025 | |
| Genmab U.S., INC. | $368.19 | 2022-2024 | Tivdak |
| Myriad Genetic Laboratories, INC. | $243.19 | 2021-2022 | |
| Clovis Oncology, INC. | $136.54 | 2020 | |
| Abbvie INC. | $129.78 | 2024-2025 | |
| Foundation Medicine, INC. | $104.64 | 2019 | |
| Eisai INC. | $51.05 | 2023-2024 | |
| Ethicon US, LLC | $40.49 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Crafton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.